Announce Date | 04/03/2025 |
EPS Normalized Actual | $3.73 (Beat by $0.07) |
EPS GAAP Actual | $3.73 (Beat by $0.07) |
Revenue Actual | $1.0063B |
Revenue Surprise | Beat by $1006.3M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2027 | 18.96 | 13.53 | 18.7666 | 19.26062 | 4 |
Aug 2026 | 0 | INF | 0 | 0 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Feb 2025) | 2.5 | 2.5 | 1.0063B | 9.98% | 1006.3M |
FQ4 2024 (Nov 2024) | 3.45 | 3.45 | 0.9516B | 1.78% | 951.6M |
FQ3 2024 (Aug 2024) | 3.86 | 3.86 | 1.0323B | 2.12% | 1032.3M |
FQ2 2024 (May 2024) | 3.69 | 3.69 | 0.9681B | -3.33% | 968.1M |
FQ1 2024 (Feb 2024) | 2.89 | 2.89 | 0.9059B | -4.16% | 905.9M |
FQ4 2023 (Nov 2023) | 3.24 | 3.24 | 0.9347B | -6.76% | 934.7M |
FQ3 2023 (Aug 2023) | 2.66 | 2.66 | 1.0104B | -9.89% | 1010.4M |
FQ2 2023 (May 2023) | 3.31 | 3.31 | 1.0003B | -6.03% | 1000.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Aug 2027) | 5.49 | -- | 5.21129 | 5.63578 | 3 |
FQ2 2027 (May 2027) | 5.2 | -- | 4.93601 | 5.33808 | 7 |
FQ1 2027 (Feb 2027) | 4.61 | -- | 4.61 | 4.61 | 2 |
FQ4 2026 (Nov 2026) | 4.77 | -- | 4.52784 | 4.89666 | 3 |
FQ3 2026 (Aug 2026) | 5.386 | -- | 5.11257 | 5.52902 | 3 |
FQ2 2026 (May 2026) | 5.01 | -- | 4.75566 | 5.14303 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Aug 2027) | 1.38B | -- | 1.33B | 1.41B | 4 |
FQ2 2027 (May 2027) | 1.3B | -- | 1.25B | 1.32B | 5 |
FQ1 2027 (Feb 2027) | 1.21B | -- | 1.21B | 1.21B | 3 |
FQ4 2026 (Nov 2026) | 1.21B | -- | 1.16B | 1.23B | 6 |
FQ3 2026 (Aug 2026) | 1.3B | -- | 1.25B | 1.32B | 3 |
FQ2 2026 (May 2026) | 1.23B | -- | 1.18B | 1.26B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | 2.5 | 2.5 | 100% | |
FQ4 2024 (Nov 2024) | 3.45 | 3.45 | 100% | |
FQ3 2024 (Aug 2024) | 3.86 | 3.86 | 100% | |
FQ2 2024 (May 2024) | 3.69 | 3.69 | 100% | |
FQ1 2024 (Feb 2024) | 2.89 | 2.89 | 100% | |
FQ4 2023 (Nov 2023) | 3.24 | 3.24 | 100% | |
FQ3 2023 (Aug 2023) | 2.66 | 2.66 | 100% | |
FQ2 2023 (May 2023) | 3.31 | 3.31 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | $0B | $1.01B | $1006.3M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0.95B | $951.6M | 100% |
FQ3 2024 (Aug 2024) | $0B | $1.03B | $1032.3M | 100% |
FQ2 2024 (May 2024) | $0B | $0.97B | $968.1M | 100% |
FQ1 2024 (Feb 2024) | $0B | $0.91B | $905.9M | 100% |
FQ4 2023 (Nov 2023) | $0B | $0.93B | $934.7M | 100% |
FQ3 2023 (Aug 2023) | $0B | $1.01B | $1010.4M | 100% |
FQ2 2023 (May 2023) | $0B | $1B | $1000.3M | 100% |